Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects
OBJECTIVE—Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals. METHODS AND RESULTS—We col...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 28; no. 9; pp. 1654 - 1659 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.09.2008
Hagerstown, MD Lippincott |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE—Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals.
METHODS AND RESULTS—We collected subcutaneous abdominal fat in 77 obese subjects (BMI ≥30 kg/m) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5±4.5 versus 2.6±1.9, P=0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5±4.4% versus 10.8±3.8%, P<0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-α mRNA expression in addition to increased plasma hs-CRP.
CONCLUSIONS—In a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects. |
---|---|
AbstractList | OBJECTIVE—Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals.
METHODS AND RESULTS—We collected subcutaneous abdominal fat in 77 obese subjects (BMI ≥30 kg/m) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5±4.5 versus 2.6±1.9, P=0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5±4.4% versus 10.8±3.8%, P<0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-α mRNA expression in addition to increased plasma hs-CRP.
CONCLUSIONS—In a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects. Objective— Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals. Methods and Results— We collected subcutaneous abdominal fat in 77 obese subjects (BMI ≥30 kg/m 2 ) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5±4.5 versus 2.6±1.9, P =0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5±4.4% versus 10.8±3.8%, P <0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-α mRNA expression in addition to increased plasma hs-CRP. Conclusions— In a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects. Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals. We collected subcutaneous abdominal fat in 77 obese subjects (BMI >or=30 kg/m(2)) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5+/-4.5 versus 2.6+/-1.9, P=0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5+/-4.4% versus 10.8+/-3.8%, P<0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-alpha mRNA expression in addition to increased plasma hs-CRP. In a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects. Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals.OBJECTIVEExperimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of inflammation in human fat in relation to vascular function and metabolic parameters in obese individuals.We collected subcutaneous abdominal fat in 77 obese subjects (BMI >or=30 kg/m(2)) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5+/-4.5 versus 2.6+/-1.9, P=0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5+/-4.4% versus 10.8+/-3.8%, P<0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-alpha mRNA expression in addition to increased plasma hs-CRP.METHODS AND RESULTSWe collected subcutaneous abdominal fat in 77 obese subjects (BMI >or=30 kg/m(2)) and quantified adipose macrophage population using targeted immunohistochemistry. Brachial artery vasodilator function was examined using high-resolution vascular ultrasound. In 50 subjects, an inflamed adipose phenotype characterized by tissue macrophage accumulation in crown-like structures was associated with systemic hyperinsulinemia and insulin resistance (HOMA-IR 5.5+/-4.5 versus 2.6+/-1.9, P=0.002) and impaired endothelium-dependent flow-mediated vasodilation (8.5+/-4.4% versus 10.8+/-3.8%, P<0.05), as compared to subjects with quiescent noninflamed adipose architecture (n=27). Macrophage retention in fat was linked to upregulated tissue CD68 and tumor necrosis factor (TNF)-alpha mRNA expression in addition to increased plasma hs-CRP.In a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects.CONCLUSIONSIn a cohort of obese subjects, we demonstrate that proinflammatory changes in adipose tissue are associated with systemic arterial dysfunction and insulin resistance. These findings suggest that adipose inflammation may be linked to vascular injury and increased cardiovascular risk in obese subjects. |
Author | Meyers, Melissa R. Ulloor, Jagadish Gagua, Manana Hess, Donald Gokce, Noyan Bigornia, Sherman Apovian, Caroline M. Mott, Melanie McDonnell, Marie Joseph, Lija |
AuthorAffiliation | From the Evans Department of Medicine and Whitaker Cardiovascular Institute (C.M.A., S.B., M.M., M.R.M., J.U., M.G., M.M., N.G.), Boston University School of Medicine, Mass; the Department of Surgery (D.H.), Boston Medical Center, Mass; and the Department of Pathology (L.J.), Boston Medical Center, Boston, Mass |
AuthorAffiliation_xml | – name: From the Evans Department of Medicine and Whitaker Cardiovascular Institute (C.M.A., S.B., M.M., M.R.M., J.U., M.G., M.M., N.G.), Boston University School of Medicine, Mass; the Department of Surgery (D.H.), Boston Medical Center, Mass; and the Department of Pathology (L.J.), Boston Medical Center, Boston, Mass – name: 3 Department of Pathology, Boston Medical Center, Boston, MA – name: 2 Department of Surgery, Boston Medical Center, Boston, MA – name: 1 Evans Department of Medicine and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA |
Author_xml | – sequence: 1 givenname: Caroline surname: Apovian middlename: M. fullname: Apovian, Caroline M. organization: From the Evans Department of Medicine and Whitaker Cardiovascular Institute (C.M.A., S.B., M.M., M.R.M., J.U., M.G., M.M., N.G.), Boston University School of Medicine, Mass; the Department of Surgery (D.H.), Boston Medical Center, Mass; and the Department of Pathology (L.J.), Boston Medical Center, Boston, Mass – sequence: 2 givenname: Sherman surname: Bigornia fullname: Bigornia, Sherman – sequence: 3 givenname: Melanie surname: Mott fullname: Mott, Melanie – sequence: 4 givenname: Melissa surname: Meyers middlename: R. fullname: Meyers, Melissa R. – sequence: 5 givenname: Jagadish surname: Ulloor fullname: Ulloor, Jagadish – sequence: 6 givenname: Manana surname: Gagua fullname: Gagua, Manana – sequence: 7 givenname: Marie surname: McDonnell fullname: McDonnell, Marie – sequence: 8 givenname: Donald surname: Hess fullname: Hess, Donald – sequence: 9 givenname: Lija surname: Joseph fullname: Joseph, Lija – sequence: 10 givenname: Noyan surname: Gokce fullname: Gokce, Noyan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20611956$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18566296$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uklv1DAUjlARXeAPcEC5wG0GO3Ec-4KUlpaOVFQJSjlajv3cuHjsIXaoKvXH4-kMI-DQk5f3LW87LPZ88FAUrzGaY0zx--7q-rg77-YYsTluUY3ps-IANxWZEVrTvXxHLZ81lFT7xWGMtwghUlXoRbGPWUNpxelB8dBpuwoRys9SjWE1yBsoF95Yl0aZbPDlIpZdjEFZmUCX320acjxOzvryC0Qbk_QKSul1eS2jmpwcy1OvQxrAWenKj_fRTF49SmXKZQ_Z6-vU34JK8WXx3EgX4dX2PCq-nZ1enZzPLi4_LU66i5lqcqEzTjVSRvdgDCgDhHBOsWoQbxhijNZGc80Qx9C2WiHEK6Zp_u8J6puaQ1MfFR82uqupX4JW4HN1TqxGu5TjvQjSin8j3g7iJvwSVVsxUtMs8G4rMIafE8QkljYqcE56CFMUlBPS1mjt9OZvp53Fn4ZnwNstIHdLOjPm9tm4w1WIYsybNY5tcHkqMY5ghLLpcSI5QesERmK9A2K7A_nNxGYHMrX6j7rL4ikS3ZDugkswxh9uuoNRDCBdGp4i_gbTqMgA |
CODEN | ATVBFA |
CitedBy_id | crossref_primary_10_1161_HYPERTENSIONAHA_120_15262 crossref_primary_10_1016_j_jhep_2009_02_031 crossref_primary_10_1210_en_2011_1765 crossref_primary_10_1016_j_metabol_2019_154027 crossref_primary_10_1007_s00259_013_2653_y crossref_primary_10_1371_journal_pone_0181500 crossref_primary_10_1097_HJH_0b013e3283340da8 crossref_primary_10_5507_bp_2018_062 crossref_primary_10_1111_1469_0691_12170 crossref_primary_10_1097_MEG_0000000000002581 crossref_primary_10_1111_j_1365_2362_2011_02606_x crossref_primary_10_4162_nrp_2012_6_5_405 crossref_primary_10_1146_annurev_med_051613_012328 crossref_primary_10_1016_j_phrs_2020_104893 crossref_primary_10_1039_D0FO03442H crossref_primary_10_1097_IN9_0000000000000039 crossref_primary_10_1517_14728222_2014_882321 crossref_primary_10_1007_s11307_018_1211_1 crossref_primary_10_1007_s00395_011_0212_x crossref_primary_10_1016_j_apsb_2020_08_015 crossref_primary_10_1021_acs_analchem_5b03696 crossref_primary_10_1007_s11154_012_9230_8 crossref_primary_10_3390_cells11081282 crossref_primary_10_1016_j_isci_2024_111292 crossref_primary_10_1016_j_ejphar_2015_06_023 crossref_primary_10_1586_erc_12_47 crossref_primary_10_1016_j_atherosclerosis_2018_09_001 crossref_primary_10_1210_jc_2018_00667 crossref_primary_10_1093_ndt_gfq246 crossref_primary_10_3390_nu5093506 crossref_primary_10_3389_fgene_2018_00175 crossref_primary_10_1016_j_jcmg_2008_11_005 crossref_primary_10_1007_s11695_008_9772_8 crossref_primary_10_3390_jcm7070159 crossref_primary_10_1158_0008_5472_CAN_17_1903 crossref_primary_10_1042_BJ20101062 crossref_primary_10_1155_2014_946492 crossref_primary_10_1016_S1646_3439_12_70008_1 crossref_primary_10_1016_j_abst_2020_09_001 crossref_primary_10_1016_j_metabol_2013_07_010 crossref_primary_10_1038_nrendo_2014_185 crossref_primary_10_1074_jbc_M116_741967 crossref_primary_10_1038_s41598_020_67177_1 crossref_primary_10_1128_IAI_02444_14 crossref_primary_10_1210_en_2016_1148 crossref_primary_10_1053_j_gastro_2013_04_010 crossref_primary_10_1111_j_1742_4658_2010_07979_x crossref_primary_10_1210_jc_2013_4483 crossref_primary_10_3390_antiox10030406 crossref_primary_10_2217_fca_14_55 crossref_primary_10_1016_j_nutres_2012_11_013 crossref_primary_10_1016_j_cmet_2009_08_003 crossref_primary_10_1016_j_cytogfr_2018_10_002 crossref_primary_10_3390_app112311565 crossref_primary_10_1007_s11892_018_1020_6 crossref_primary_10_1016_j_jtv_2019_10_002 crossref_primary_10_1016_j_jff_2018_07_010 crossref_primary_10_1161_ATVBAHA_111_230979 crossref_primary_10_3945_ajcn_2009_28473A crossref_primary_10_1161_ATVBAHA_119_312467 crossref_primary_10_1051_medsci_20112711016 crossref_primary_10_1038_nrendo_2015_128 crossref_primary_10_1016_j_smaim_2024_07_002 crossref_primary_10_1586_eem_10_68 crossref_primary_10_3389_fphar_2020_606514 crossref_primary_10_1016_j_jnutbio_2015_12_005 crossref_primary_10_1007_s11906_010_0150_2 crossref_primary_10_1080_01635581_2023_2180824 crossref_primary_10_1002_jor_23280 crossref_primary_10_1161_JAHA_115_002545 crossref_primary_10_1161_CIRCRESAHA_118_311912 crossref_primary_10_1038_ijo_2015_100 crossref_primary_10_1016_j_jhep_2011_12_015 crossref_primary_10_1097_MED_0b013e3283292327 crossref_primary_10_1152_ajpendo_00075_2015 crossref_primary_10_1016_j_jacc_2011_01_051 crossref_primary_10_2174_1566524023666230710120438 crossref_primary_10_1210_endocr_bqac124 crossref_primary_10_1097_RCT_0000000000001066 crossref_primary_10_1007_s11906_016_0696_8 crossref_primary_10_1021_ac301082d crossref_primary_10_1155_2012_124693 crossref_primary_10_1016_j_it_2010_03_001 crossref_primary_10_1053_j_gastro_2014_02_008 crossref_primary_10_2337_db10_1263 crossref_primary_10_1097_MEG_0000000000000597 crossref_primary_10_1016_j_mam_2012_10_001 crossref_primary_10_1111_j_1365_2362_2009_02239_x crossref_primary_10_1038_s41387_023_00249_z crossref_primary_10_1016_j_mam_2012_10_003 crossref_primary_10_1002_term_1565 crossref_primary_10_1016_j_physbeh_2024_114643 crossref_primary_10_1155_2013_489187 crossref_primary_10_1371_journal_pone_0006733 crossref_primary_10_3390_genes10080589 crossref_primary_10_1016_j_ijcard_2018_08_088 crossref_primary_10_1530_REP_10_0074 crossref_primary_10_3390_ijms26051790 crossref_primary_10_1016_j_vaccine_2013_05_003 crossref_primary_10_3389_fpubh_2023_1107158 crossref_primary_10_1016_j_metabol_2013_12_002 crossref_primary_10_1080_19490976_2024_2359515 crossref_primary_10_1093_gerona_glaa056 crossref_primary_10_1590_s2175_979020201000x42e19375 crossref_primary_10_1016_j_jjcc_2013_11_006 crossref_primary_10_1007_s00395_018_0702_1 crossref_primary_10_1210_jc_2017_02301 crossref_primary_10_1097_RUQ_0000000000000256 crossref_primary_10_1002_oby_21900 crossref_primary_10_1126_sciadv_abe2480 crossref_primary_10_3389_fimmu_2021_670566 crossref_primary_10_1038_oby_2012_54 crossref_primary_10_1210_jc_2014_1780 crossref_primary_10_1111_jch_13936 crossref_primary_10_1002_edm2_20 crossref_primary_10_1210_en_2010_0916 crossref_primary_10_1210_clinem_dgaa158 crossref_primary_10_1073_pnas_1911468116 crossref_primary_10_1530_JOE_14_0283 crossref_primary_10_3389_fcdhc_2022_947552 crossref_primary_10_2337_db13_1511 crossref_primary_10_1016_j_diabet_2009_05_001 crossref_primary_10_1016_j_molmet_2017_08_016 crossref_primary_10_1096_fj_202401871R crossref_primary_10_2174_1570161117666190121102323 crossref_primary_10_1586_14779072_7_3_209 crossref_primary_10_1016_j_arr_2022_101611 crossref_primary_10_1038_nrcardio_2014_80 crossref_primary_10_1038_s44324_024_00026_1 crossref_primary_10_1002_JLB_5RI0917_380RR crossref_primary_10_1007_s11883_014_0441_1 crossref_primary_10_1007_s11695_013_0894_2 crossref_primary_10_1177_17534259231193926 crossref_primary_10_4103_jcn_jcn_65_21 crossref_primary_10_1080_21623945_2019_1569448 crossref_primary_10_1111_j_1467_789X_2009_00638_x crossref_primary_10_1111_obr_12811 crossref_primary_10_1016_j_bpg_2013_03_003 crossref_primary_10_1002_jcp_25189 crossref_primary_10_1038_nutd_2012_3 crossref_primary_10_1016_j_exger_2022_111931 crossref_primary_10_15212_CVIA_2016_0027 crossref_primary_10_1016_j_biopha_2020_110103 crossref_primary_10_1016_j_mce_2010_05_020 crossref_primary_10_1016_j_bbrc_2010_11_127 crossref_primary_10_1042_CS20200356 crossref_primary_10_1371_journal_pone_0082163 crossref_primary_10_1016_j_nut_2020_110942 crossref_primary_10_3389_fimmu_2022_977485 crossref_primary_10_1016_j_jff_2024_106407 crossref_primary_10_3390_metabo11020062 crossref_primary_10_4049_jimmunol_1801470 crossref_primary_10_12998_wjcc_v9_i20_5358 crossref_primary_10_1139_cjpp_2016_0663 crossref_primary_10_1097_QAI_0000000000000458 crossref_primary_10_1161_JAHA_113_000312 crossref_primary_10_1371_journal_pone_0112569 crossref_primary_10_2217_WHE_11_36 crossref_primary_10_3390_ijms18061216 crossref_primary_10_1016_j_pcad_2014_12_005 crossref_primary_10_3390_jpm13040594 crossref_primary_10_1186_s40168_021_01097_8 crossref_primary_10_1016_j_jhep_2017_09_021 crossref_primary_10_1016_j_metabol_2017_04_005 crossref_primary_10_3390_nu5062019 crossref_primary_10_1016_j_jcmg_2012_11_021 crossref_primary_10_2217_clp_10_89 crossref_primary_10_1210_en_2010_0571 crossref_primary_10_1007_s11695_012_0706_0 crossref_primary_10_1093_ejendo_lvad031 crossref_primary_10_1126_science_1188280 crossref_primary_10_1002_oby_21943 crossref_primary_10_1016_j_atherosclerosis_2012_01_031 crossref_primary_10_2337_dc14_2775 crossref_primary_10_1177_1559827614552986 crossref_primary_10_1038_oby_2009_482 crossref_primary_10_1038_ijo_2010_112 crossref_primary_10_3760_cma_j_issn_0366_6999_20133011 crossref_primary_10_1002_oby_21252 crossref_primary_10_1093_eurheartj_eht467 crossref_primary_10_2337_dc13_0256 crossref_primary_10_1007_s10620_016_4127_0 crossref_primary_10_1371_journal_pone_0031274 crossref_primary_10_1186_2251_6581_13_35 crossref_primary_10_1371_journal_pone_0078320 crossref_primary_10_1007_s11357_019_00137_4 crossref_primary_10_1111_obr_12242 crossref_primary_10_1007_s11892_009_0006_9 crossref_primary_10_1016_j_ygyno_2021_02_032 crossref_primary_10_3389_fphys_2018_00253 crossref_primary_10_1016_j_metabol_2018_10_011 crossref_primary_10_1017_S002966511200078X crossref_primary_10_1016_j_bbrc_2018_09_070 crossref_primary_10_1152_physiolgenomics_00172_2013 crossref_primary_10_1161_ATVBAHA_113_301393 crossref_primary_10_1161_CIRCRESAHA_110_218651 crossref_primary_10_1111_j_1600_065X_2012_01142_x crossref_primary_10_1038_ncomms5982 crossref_primary_10_1139_cjpp_2012_0295 crossref_primary_10_1016_j_nut_2012_05_012 crossref_primary_10_1097_CM9_0000000000002601 crossref_primary_10_1139_apnm_2018_0611 crossref_primary_10_1186_1743_7075_8_27 crossref_primary_10_1371_journal_pone_0196755 crossref_primary_10_1371_journal_pone_0208156 crossref_primary_10_1097_MCO_0b013e32833aabef crossref_primary_10_1038_s41467_024_48935_5 crossref_primary_10_1007_s12192_015_0653_5 crossref_primary_10_1007_s00125_016_4158_2 crossref_primary_10_1007_s11883_019_0817_3 crossref_primary_10_3389_fendo_2022_856530 crossref_primary_10_1210_js_2017_00020 crossref_primary_10_1016_j_numecd_2019_05_063 crossref_primary_10_1155_2013_616193 crossref_primary_10_1016_j_metabol_2013_07_006 crossref_primary_10_1038_s41387_019_0071_3 crossref_primary_10_2147_NSS_S374572 crossref_primary_10_1161_ATVBAHA_111_235846 crossref_primary_10_1016_j_niox_2021_09_001 crossref_primary_10_1210_jc_2010_2541 crossref_primary_10_1016_j_metabol_2011_10_004 crossref_primary_10_3389_fcvm_2021_681581 crossref_primary_10_1096_fj_15_271452 crossref_primary_10_1152_ajpendo_00025_2009 crossref_primary_10_1016_j_cmet_2010_04_013 crossref_primary_10_1096_fj_10_178657 crossref_primary_10_1111_j_1749_6632_2010_05875_x crossref_primary_10_1111_micc_12540 crossref_primary_10_1530_JOE_13_0201 crossref_primary_10_1002_mco2_70030 crossref_primary_10_1371_journal_pone_0106300 crossref_primary_10_1016_j_physbeh_2018_11_035 crossref_primary_10_1371_journal_pone_0237496 crossref_primary_10_3390_ijms15046184 crossref_primary_10_1016_j_jtemb_2014_10_011 crossref_primary_10_1152_ajpendo_00109_2020 crossref_primary_10_1016_j_amjmed_2011_07_017 crossref_primary_10_1016_j_ejphar_2021_174320 crossref_primary_10_1111_dom_14055 crossref_primary_10_1007_s00018_016_2320_0 crossref_primary_10_3389_fphar_2021_626313 crossref_primary_10_1038_gene_2011_14 crossref_primary_10_1093_nar_gky1190 crossref_primary_10_1161_CIRCRESAHA_112_266395 crossref_primary_10_3748_wjg_v22_i2_681 crossref_primary_10_1002_oby_21507 crossref_primary_10_1053_j_ackd_2021_06_001 crossref_primary_10_1186_s12933_020_01163_9 crossref_primary_10_1080_21623945_2020_1787582 crossref_primary_10_3945_an_116_013847 crossref_primary_10_1038_nri2921 crossref_primary_10_1210_endocr_bqad151 crossref_primary_10_1002_iub_2805 crossref_primary_10_1097_MED_0000000000000185 crossref_primary_10_1038_ijo_2014_27 crossref_primary_10_1097_MED_0b013e328329fcc2 crossref_primary_10_1530_JME_12_0080 crossref_primary_10_1016_j_ijcard_2013_01_158 crossref_primary_10_2337_db09_0287 crossref_primary_10_2174_0929867327666200716113136 crossref_primary_10_1155_2013_393192 crossref_primary_10_1074_jbc_M109_088708 crossref_primary_10_1161_CIRCRESAHA_115_306885 crossref_primary_10_3389_fphys_2020_570270 crossref_primary_10_1016_j_ijcard_2013_06_059 |
Cites_doi | 10.1056/NEJMsr043743 10.1016/S0076-6879(02)59183-7 10.1210/jc.2005-0482 10.1016/j.tcm.2005.10.002 10.1172/JCI27280 10.1016/S0735-1097(03)00994-X 10.1172/JCI24335 10.1172/JCI200319451 10.1056/NEJMoa072515 10.1172/JCI200319246 10.2337/diabetes.54.8.2277 10.1172/JCI20514 10.1111/j.1463-1326.2005.00505.x 10.1161/circ.99.25.3234 10.1161/circulationaha.106.649939 10.1210/en.2007-1312 10.1161/01.cir.0000072765.93106.ee 10.1152/ajpendo.00645.2007 10.1016/j.jacc.2006.08.011 10.1194/jlr.M500294-JLR200 10.1172/JCI29069 10.1161/01.cir.0000012543.55874.47 10.2337/db06-0133 10.2337/diabetes.54.8.2305 10.1161/circulationaha.107.710509 10.1172/JCI117936 10.1161/01.cir.0000025404.78001.d8 10.1126/science.7678183 10.1161/circulationaha.106.685230 10.1161/circulationaha.106.652859 10.1001/jama.296.1.79 10.1161/CIRCULATIONAHA.106.675355 10.1161/01.cir.0000112565.60887.1e 10.1038/sj.ijo.0801022 10.1210/jc.2006-1811 10.2337/db07-0111 10.1172/JCI118709 10.1001/jama.291.23.2847 10.2337/db07-0767 |
ContentType | Journal Article |
Copyright | 2008 American Heart Association, Inc. 2008 INIST-CNRS |
Copyright_xml | – notice: 2008 American Heart Association, Inc. – notice: 2008 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1161/ATVBAHA.108.170316 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 1659 |
ExternalDocumentID | PMC2728436 18566296 20611956 10_1161_ATVBAHA_108_170316 10.1161/ATVBAHA.108.170316 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL074097 – fundername: NHLBI NIH HHS grantid: R01 HL084213 – fundername: NHLBI NIH HHS grantid: HL084213 |
GroupedDBID | --- .3C .55 .GJ .Z2 01R 0R~ 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFS ACGOD ACILI ACLDA ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AGINI AHJKT AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B N~M O9- OAG OAH OB2 OCUKA ODA OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ PZZ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WOQ WOW X3V X3W X7M XXN XYM YFH ZGI ZZMQN AAYXX ADGHP CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c5116-96d0cfdbeffecfe449961c5095808863fd9d8091e77dc00928d6886b40b539e53 |
ISSN | 1079-5642 1524-4636 |
IngestDate | Thu Aug 21 18:09:22 EDT 2025 Thu Jul 10 18:52:19 EDT 2025 Mon Jul 21 05:36:08 EDT 2025 Mon Jul 21 09:16:12 EDT 2025 Thu Apr 24 23:01:46 EDT 2025 Tue Jul 01 02:21:27 EDT 2025 Fri May 16 03:46:46 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Endocrinopathy Human Obesity vasculature Pancreatic hormone Nutrition disorder Metabolic diseases Cardiovascular disease Inflammation Insulin Endothelium Vascular disease Target tissue resistance Vascular resistance Atherosclerosis Endothelial dysfunction Insulin resistance Infiltration Nutritional status Macrophage |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5116-96d0cfdbeffecfe449961c5095808863fd9d8091e77dc00928d6886b40b539e53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/2728436 |
PMID | 18566296 |
PQID | 69447305 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2728436 proquest_miscellaneous_69447305 pubmed_primary_18566296 pascalfrancis_primary_20611956 crossref_citationtrail_10_1161_ATVBAHA_108_170316 crossref_primary_10_1161_ATVBAHA_108_170316 wolterskluwer_health_10_1161_ATVBAHA_108_170316 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-September |
PublicationDateYYYYMMDD | 2008-09-01 |
PublicationDate_xml | – month: 09 year: 2008 text: 2008-September |
PublicationDecade | 2000 |
PublicationPlace | Philadelphia, PA Hagerstown, MD |
PublicationPlace_xml | – name: Philadelphia, PA – name: Hagerstown, MD – name: United States |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2008 |
Publisher | American Heart Association, Inc Lippincott |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_1_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 e_1_3_3_21_2 |
References_xml | – ident: e_1_3_3_1_2 doi: 10.1056/NEJMsr043743 – ident: e_1_3_3_16_2 doi: 10.1016/S0076-6879(02)59183-7 – ident: e_1_3_3_37_2 doi: 10.1210/jc.2005-0482 – ident: e_1_3_3_13_2 doi: 10.1016/j.tcm.2005.10.002 – ident: e_1_3_3_4_2 doi: 10.1172/JCI27280 – ident: e_1_3_3_12_2 doi: 10.1016/S0735-1097(03)00994-X – ident: e_1_3_3_8_2 doi: 10.1172/JCI24335 – ident: e_1_3_3_5_2 doi: 10.1172/JCI200319451 – ident: e_1_3_3_2_2 doi: 10.1056/NEJMoa072515 – ident: e_1_3_3_6_2 doi: 10.1172/JCI200319246 – ident: e_1_3_3_18_2 doi: 10.2337/diabetes.54.8.2277 – ident: e_1_3_3_7_2 doi: 10.1172/JCI20514 – ident: e_1_3_3_29_2 doi: 10.1111/j.1463-1326.2005.00505.x – ident: e_1_3_3_15_2 doi: 10.1161/circ.99.25.3234 – ident: e_1_3_3_22_2 doi: 10.1161/circulationaha.106.649939 – ident: e_1_3_3_39_2 doi: 10.1210/en.2007-1312 – ident: e_1_3_3_25_2 doi: 10.1161/01.cir.0000072765.93106.ee – ident: e_1_3_3_38_2 doi: 10.1152/ajpendo.00645.2007 – ident: e_1_3_3_10_2 doi: 10.1016/j.jacc.2006.08.011 – ident: e_1_3_3_17_2 doi: 10.1194/jlr.M500294-JLR200 – ident: e_1_3_3_3_2 doi: 10.1172/JCI29069 – ident: e_1_3_3_23_2 doi: 10.1161/01.cir.0000012543.55874.47 – ident: e_1_3_3_31_2 doi: 10.2337/db06-0133 – ident: e_1_3_3_9_2 doi: 10.2337/diabetes.54.8.2305 – ident: e_1_3_3_35_2 doi: 10.1161/circulationaha.107.710509 – ident: e_1_3_3_27_2 doi: 10.1172/JCI117936 – ident: e_1_3_3_24_2 doi: 10.1161/01.cir.0000025404.78001.d8 – ident: e_1_3_3_26_2 doi: 10.1126/science.7678183 – ident: e_1_3_3_36_2 doi: 10.1161/circulationaha.106.685230 – ident: e_1_3_3_11_2 doi: 10.1161/circulationaha.106.652859 – ident: e_1_3_3_20_2 doi: 10.1001/jama.296.1.79 – ident: e_1_3_3_34_2 doi: 10.1161/CIRCULATIONAHA.106.675355 – ident: e_1_3_3_14_2 doi: 10.1161/01.cir.0000112565.60887.1e – ident: e_1_3_3_30_2 doi: 10.1038/sj.ijo.0801022 – ident: e_1_3_3_33_2 doi: 10.1210/jc.2006-1811 – ident: e_1_3_3_19_2 doi: 10.2337/db07-0111 – ident: e_1_3_3_28_2 doi: 10.1172/JCI118709 – ident: e_1_3_3_21_2 doi: 10.1001/jama.291.23.2847 – ident: e_1_3_3_32_2 doi: 10.2337/db07-0767 |
SSID | ssj0004220 |
Score | 2.4380105 |
Snippet | OBJECTIVE—Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the... Objective— Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the... Experimental studies suggest that adipose inflammation is etiologically linked to obesity-induced systemic disease. Our goal was to characterize the state of... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1654 |
SubjectTerms | Abdominal Fat - immunology Abdominal Fat - physiopathology Adult Antigens, CD - analysis Antigens, CD - genetics Antigens, Differentiation, Myelomonocytic - analysis Antigens, Differentiation, Myelomonocytic - genetics Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Blood vessels and receptors Brachial Artery - physiopathology C-Reactive Protein - analysis Cardiology. Vascular system Cohort Studies Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Endothelium, Vascular - diagnostic imaging Endothelium, Vascular - physiopathology Female Fundamental and applied biological sciences. Psychology Humans Immunohistochemistry Insulin Resistance Macrophages - immunology Male Medical sciences Middle Aged Obesity - diagnostic imaging Obesity - immunology Obesity - physiopathology Panniculitis - diagnostic imaging Panniculitis - immunology Panniculitis - physiopathology Phenotype Polymerase Chain Reaction RNA, Messenger - analysis Tumor Necrosis Factor-alpha - analysis Tumor Necrosis Factor-alpha - genetics Ultrasonography Vasodilation Vertebrates: cardiovascular system |
Title | Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18566296 https://www.proquest.com/docview/69447305 https://pubmed.ncbi.nlm.nih.gov/PMC2728436 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBDShPimfAw_8IayNanz4cds2lTBNoTUor1FceyuEV1SkRYE4u_h7-QusZ1Eq8bHS9Q6cezmfvHdub-7I-SNn3EJqkE6Aqxjh4FB7ESRz2AxVCOueCSZqAmy58Fkxt5d-BeDwa8Oa2mzFvvZj61xJf8jVWgDuWKU7D9I1t4UGuAzyBeOIGE4_pWMY5mvkG9-lWIhrgXSb-C2-VKnwsVi5al-_IZlbrjn4GWj5WjiBSwhVRUSY7KWuJEuv1eo9gwdshQKxqo2Arduqq5VGyMvNC8rmB4o3SZrAdZfuBLmW28MnfjJYm1Vfs2bfdijpoiQavdoD_PLOnKs3qVdoBqxaD4zXBO1xDh526x0HQs8AbBKNSfSbG1ElrtlV2OPOZjRrFFWW9r0Eu5FHajyznqMsVrbFUWAiiKefjqMJzESLfddzOS_JSv3-YfkZHZ6mkyPL6a3yG0P3BGslPH-YycrvVen_7RTM8FZgXtwfYSeAbS7gkefLudNEZVtXs51su7utxKJFNXnOo6iYw1N75N72o2hcYPJB2SgiofkzpkmajwiPzU0aQtN2oUmzSvaQpMiNKmGJm2hSQE21MCGdqBJO9CEfrSGJjXQfExmJ8fTo4mjC304Gdj7gcMDOcrmUtQUprli4IUHbgamrB-BEgzGc8llBIatCkOZYZawSAbQLthI-GOu_PETslOUhXpGKG4A-BljIx6lYAOMolByITLluW44zxQfEtc8_STTWfCxGMsyqb3hwE20xDBzbtJIbEje2j6rJgfMjVfv9YRqu3hgOmN07pC8NlJOYC3HP-jSQpWbKgk4Y6Bx_SF52si8HS4Ct8vj0DfsocFegFni-2eKfFFni_dCsEDH0POgh5ukibO-4Yc8_-M8X5C77Wv7kuysv2zUK7DR12KvfkF-A0yT7os |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adipose+macrophage+infiltration+is+associated+with+insulin+resistance+and+vascular+endothelial+dysfunction+in+obese+subjects&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Apovian%2C+Caroline+M&rft.au=Bigornia%2C+Sherman&rft.au=Mott%2C+Melanie&rft.au=Meyers%2C+Melissa+R&rft.date=2008-09-01&rft.issn=1524-4636&rft.eissn=1524-4636&rft.volume=28&rft.issue=9&rft.spage=1654&rft_id=info:doi/10.1161%2FATVBAHA.108.170316&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |